Prof. Yael Cohen is the head the Myeloma unit at the Tel Aviv Sourasky Medical Center, and the head of the Israeli Myeloma working group within the Israeli medical association. She is an associate professor of Medicine at the Sackler faculty of medicine. Yael serves the ministry of health central ethics committee for clinical trials. She leads and participates in multiple research projects and clinical trials in Israel and internationally.
Prof. Cohen has over 90 publications in international medical meetings and peer reviewed journals.
She spent several years in various leadership positions in the pharma industry, as a medical director at Merck (Israel and US) and as VP of clinical development at Gamida cell and at VBL Therapeutics.